Potential strategies for improving the results of high-dose chemotherapy in patients with metastatic breast cancer.

Abstract

High-dose chemotherapy (HDC) is the most effective approach for inducing complete remissions in patients with metastatic breast cancer, and although most patients will relapse, a small percentage (10%-15%) achieve durable remissions beyond five years. Additionally, HDC has produced five-year relapse-free survival rates in excess of 70% in patients with… (More)

Topics

  • Presentations referencing similar topics